ReviewFrontiers in neurology
The microenvironmental mechanism of postoperative recurrence in cervical spondylotic myelopathy: regulation by the glial scar-inflammation axis.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical spondylotic myelopathy (CSM) is a severe degenerative spinal disorder caused by cervical spinal stenosis due to cervical degeneration, which compresses the spinal cord. Patients in the mid-to late-stages of the disease frequently undergo surgical treatment; however, some may still suffer from persistent sensorimotor dysfunction, inadequate pain relief, and surgery-related complications. Although substantial progress has been achieved in comprehending the pathology of CSM in recent years, the postoperative pathological mechanisms remain poorly understood, particularly the specific molecular mechanisms influencing the development of complications. Traditional research has focused on mechanical compression caused by herniated material, neglecting the potential adverse effects of postoperative immune microenvironment imbalance in the spinal cord. Current studies suggest that the glial scar-inflammation axis, which is triggered by abnormal activation of neural immune cells (glia) and peripheral immune cells (e.g., Th17 cells and neutrophils) and their interactions-may serve as a key factor contributing to poor postoperative outcomes and disease recurrence. This review summarizes the recent advances in the biology and pathology of the glial scar-inflammation axis following conventional surgical treatment for CSM, as well as innovative therapeutic strategies, such as stem cell transplantation. It aims to provide new insights and directions for future research on postoperative complications and their treatment in CSM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.